| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―08 |
COVID-19 vaccination prevents venous thrombosis in patients with SARS-CoV-2 infection and thereafter |
Giuseppe Lippi, Emmanuel J. Favaloro |
| 2 |
[GO] |
2024―Apr―16 |
Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis |
Saeed Hassani, Mohammad Sayyadi, Amir Almasi-Hashiani |
| 3 |
[GO] |
2023―Oct―13 |
Diagnosis and treatment of coagulopathy using thromboelastography with platelet mapping is associated with decreased risk of pulmonary failure in COVID-19 patients |
Tjasa Hranjec, Mackenzie Mayhew, Bradley Rogers, Rachele Solomon, Deborah Hurst, Michael Estreicher, Alberto Augusten, Aaron Nunez, Melissa Green, Shivali Malhotra, Randy Katz, Andrew Rosenthal, Sara Hennessy, Paul Pepe, Robert Sawyer, Juan Arenas |
| 4 |
[GO] |
2023―Sep―27 |
Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic |
Jennifer Davila, William B. Mitchell, Kerry Morrone, Ellen J. Silver, Caterina P. Minniti, Henny H. Billett, Payal C. Desai, Sarah H. O’Brien, Deepa Manwani |
| 5 |
[GO] |
2023―Mar―27 |
The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection |
Haifa M. AlNafea, Aida A. Korish |
| 6 |
[GO] |
2023―Jan―31 |
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology |
Minoo Shahidi, Mohammad Reza Amirzargar |
| 7 |
[GO] |
2022―Sep―27 |
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations |
Burcu Altındağ Avcı, Mustafa Doğan, Bahadır Batar, İlker Yıldırım, Elif Serdal, Sümbül Gezer, Çağatay L. Onar, Seval Akpınar, Burhan Turgut |
| 8 |
[GO] |
2022―Aug―10 |
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination |
Mona Al-Ahmad, Mona Al Rasheed, Lulwa Altourah, Tito Rodriguez-Bouza, Neveen Shalaby |
| 9 |
[GO] |
2022―Jul―14 |
Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection |
Tamara Lado Cives, Marta Fernández Docampo, María Teresa Fernández Fernández, Diana Martínez Señarís, Alejandro Hevilla Carmona, Almudena Pérez-Rodríguez, María del Carmen Gómez del Castillo Solano, María Fernanda López Fernández |
| 10 |
[GO] |
2022―Jun―15 |
Postacute elevation of D-dimer levels in severe acute respiratory syndrome coronavirus 2-positive nonhospitalized patients with mild symptoms |
Rebecca Folkman, Habiba Kamal, Marcus Ahl, Adrian Szum, Maria Magnusson, Soo Aleman |
| 11 |
[GO] |
2022―Mar―03 |
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients |
Fatma Demet Arslan, Banu İşbilen Başok, Mustafa Terzioğlu, Tuba Kansu Altan, Yeşer Karaca, Süheyla Serin Senger, Ayfer Çolak |
| 12 |
[GO] |
2022―Jan―04 |
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination |
Reem H. Matar, Christian A. Than, Hayato Nakanishi, Rohan Suresh Daniel, Karen Smayra, Bernice L. Sim, Azizullah Beran, Omar A. Danoun |
| 13 |
[GO] |
2021―Dec―23 |
The effects of lung involvement, clinical and laboratory parameters on outcome in elderly patients with coronavirus disease 2019 |
Ferda Bilgir, Şebnem Çalık, İsmail Demir, Özden Yıldırım Akan, Oktay Bilgir |
| 14 |
[GO] |
2021―Dec―04 |
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists |
Nikola Pantic, Nada Suvajdzic-Vukovic, Marijana Virijevic, Zlatko Pravdic, Nikica Sabljic, Tatjana Adzic-Vukicevic, Mirjana Mitrovic |
| 15 |
[GO] |
2021―Oct―25 |
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury |
Luca Arcari, Michelangelo Luciani, Luca Cacciotti, Maria Beatrice Musumeci, Valerio Spuntarelli, Enrico Bentivegna, Giovanni Camastra, Gerardo Ansalone, Claudio Santini, Paolo Martelletti, Massimo Volpe, Luciano De Biase |
| 16 |
[GO] |
2021―Oct―25 |
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura |
Kaitlyn C. Dykes, Craig M. Kessler |
| 17 |
[GO] |
2021―Sep―06 |
ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia |
Noppacharn Uaprasert, Krissana Panrong, Songphol Tungjitviboonkun, Kulwara Dussadee, Pakanat Decharatanachart, Peerapat Kaveevorayan, Rossanun Shoosanglertwijit, Phandee Watanaboonyongcharoen, Udomsak Bunworasate, Ponlapat Rojnuckarin |
| 18 |
[GO] |
2021―Aug―09 |
Thrombogenicity markers for early diagnosis and prognosis in COVID-19 |
Paul A. Gurbel, Kevin P. Bliden, Jerrold H. Levy, Naval Walia, Nicole Rapista, Alastair Cho, Christophe Jerjian, Udaya S. Tantry |
| 19 |
[GO] |
2021―Jul―29 |
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings |
Nergiz Bayrakci, Gulsum Ozkan, Levent Cem Mutlu, lknur Erdem, Ilker Yildirim, Dumrul Gulen, Aliye Celikkol |
| 20 |
[GO] |
2021―Jul―26 |
A mild deficiency of ADAMTS13 is associated with severity in COVID-19 |
Reyes María Martín-Rojas, Maite Chasco-Ganuza, Sara Casanova-Prieto, Valeria Estefanía Delgado-Pinos, Gloria Pérez-Rus, Patricia Duque-González, Milagros Sancho, José Luis Díez-Martín, Cristina Pascual-Izquierdo |
| 21 |
[GO] |
2021―May―19 |
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2 |
Matthias Karer, Karin Stiasny, Markus Zeitlinger, Bernd Jilma |
| 22 |
[GO] |
2021―Mar―20 |
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management |
Kanjaksha Ghosh, Malay Ghosh |
| 23 |
[GO] |
2021―Feb―22 |
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019 |
Akbar Dorgalaleh, Shadi Tabibian, Mohammad Reza Baghaipour, Ali Dabbagh, Gholamreza Bahoush, Mohammad Jazebi, Mehran Bahraini, Alieh Fazeli, Forough Yousefi |
| 24 |
[GO] |
2021―Jan―25 |
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019 |
Patricia Duque, Maite Chasco-Ganuza, Alba Burgos-Santamaria, Estrella Terradillos |
| 25 |
[GO] |
2021―Jan―14 |
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection |
Joseph Bennett, Mark T. Cunningham, Christin Howard, Marc Hoffmann, Fred V. Plapp |
| 26 |
[GO] |
2021―Jan―14 |
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU |
Raf De Jongh, Marisa Ninivaggi, Dieter Mesotten, Cui Bai, Berend Marcus, Dana Huskens, Hendrik Stragier, Adam Miszta, Jasmine Verbruggen, Romy M.W. de Laat-Kremers, Jef Grieten, Bas de Laat |
| 27 |
[GO] |
2021―Jan―14 |
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia |
Raimondo De Cristofaro, Giovanna Liuzzo, Monica Sacco, Stefano Lancellotti, Daniela Pedicino, Felicita Andreotti |
| 28 |
[GO] |
2021―Jan―14 |
Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients |
Mansour Gergi, Andrew Goodwin, Kalev Freeman, Christos Colovos, Oksana Volod |
| 29 |
[GO] |
2021―Jan―13 |
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors |
Maria-Teresa Calderon-Lopez, Natalia Garcia-Leon, Sergio Gomez-Arevalillo, Purificacion Martin-Serrano, Arturo Matilla-Garcia |
| 30 |
[GO] |
2020―Dec―03 |
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit |
Amer Hamadé, Bastien Woehl, Ines Harzallah, Marjolaine Talbot, Jonathan Tousch, Lucas Jambert |
| 31 |
[GO] |
2020―Nov―17 |
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019 |
Rohit S. Loomba, Gaurav Aggarwal, Enrique G. Villarreal, Juan S. Farias, Saul Flores, Carl J. Lavie, Saurabh Aggarwal |
| 32 |
[GO] |
2020―Nov―17 |
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneumonia |
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Andrew Horton, Lorenzo R. Suardi |
| 33 |
[GO] |
2020―Nov―11 |
The association of oxygen saturation, tomography findings and d-dimer levels in coronavirus disease 2019 patients |
Kadir S. Yalçin, Benan Kasapoğlu, Recep Alanli, Murat B. Küçükay, Ali Koşar |
| 34 |
[GO] |
2020―Sep―06 |
Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children |
Hyppolite Kuekou Tchidjou, Fiorella Caron, Adeline Ferec, Karine Braun, Loic Hery, Sandrine Castelain, Bernard Romeo |
| 35 |
[GO] |
2020―Jul―02 |
D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019 |
William G. Lima, Ayslan Barra, Júlio César M. Brito, Waleska S.C. Nizer |
